Literature DB >> 11246219

Expression of ATM in ataxia telangiectasia fibroblasts rescues defects in DNA double-strand break repair in nuclear extracts.

Y Li1, M P Carty, G G Oakley, M M Seidman, M Medvedovic, K Dixon.   

Abstract

Ataxia telangiectasia (A-T) is a human genetic disorder characterized by progressive cerebellar degeneration, hypersensitivity to ionizing radiation (IR), immunodeficiency, and high cancer risk. At the cellular level, IR sensitivity and increased frequency of spontaneous and IR-induced chromosomal breakage and rearrangements are the hallmarks of A-T. The ATM gene, mutated in this syndrome, has been cloned and codes for a protein sharing homology with DNA-PKcs, a protein kinase involved in DNA double-strand break (DSB) repair and DNA damage responses. The characteristics of the A-T cellular phenotypes and ATM gene suggest that ATM may play a role similar to that of DNA-PKcs in DSB repair and that there is a primary DNA repair defect in A-T cells. In the current study, the function of ATM in DNA DSB repair was evaluated in an in vitro system using two plasmids, carrying either an EcoRI-induced DSB within the lacZalpha gene or various endonuclease-induced DSB in the SupF suppressor tRNA gene. We found that the DSB repair efficiency in A-T nuclear extracts was comparable to, if not higher than, that in normal nuclear extracts. However, the repair fidelity in A-T nuclear extracts was decreased when repairing DSB with short 5' and 3' overhangs (<4 base pairs (bp)) or blunt ends, but not 5' 4-bp overhangs. Sequencing of the mutant plasmids revealed that deletions involving 1-6 nucleotide microhomologies were the major class of mutations in both A-T and normal extracts. However, the size of the deletions in plasmids from A-T nuclear extracts was larger than that from normal nuclear extracts. Expression of the ATM protein in A-T cells corrected the defect in DSB repair in A-T nuclear extracts. These results suggest that ATM plays a role in maintaining genomic stability by preventing the repair of DSB from an error-prone pathway. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246219     DOI: 10.1002/em.1020

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

1.  ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining.

Authors:  Elias A Rahal; Leigh A Henricksen; Yuling Li; R Scott Williams; John A Tainer; Kathleen Dixon
Journal:  Cell Cycle       Date:  2010-07-12       Impact factor: 4.534

2.  Evaluation of a Small Animal Irradiation System for Animal Experiments Using EBT3 Model GAFCHROMIC™ Film.

Authors:  Yasuyuki Shimizu; Hiroaki Akasaka; Daisuke Miyawaki; Naritoshi Mukumoto; Masao Nakayama; Tianyuan Wang; Saki Osuga; Sachiko Inubushi; Ryuichi Yada; Yasuo Ejima; Kenji Yoshida; Takeaki Ishihara; Ryohei Sasaki
Journal:  Kobe J Med Sci       Date:  2018-01-17

Review 3.  DNA repair targeted therapy: The past or future of cancer treatment?

Authors:  Navnath S Gavande; Pamela S VanderVere-Carozza; Hilary D Hinshaw; Shadia I Jalal; Catherine R Sears; Katherine S Pawelczak; John J Turchi
Journal:  Pharmacol Ther       Date:  2016-02-16       Impact factor: 12.310

4.  ATM mediates repression of DNA end-degradation in an ATP-dependent manner.

Authors:  Elias A Rahal; Leigh A Henricksen; Yuling Li; John J Turchi; Katherine S Pawelczak; Kathleen Dixon
Journal:  DNA Repair (Amst)       Date:  2008-01-22

5.  Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice.

Authors:  Jun Feng; Jian Zou; Li Li; Yongsheng Zhao; Shixi Liu
Journal:  J Exp Clin Cancer Res       Date:  2011-04-17

6.  Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice.

Authors:  Jian Zou; Xiaoming Qiao; Huiping Ye; Yuqiong Yang; Xuelian Zheng; Houyu Zhao; Shixi Liu
Journal:  J Exp Clin Cancer Res       Date:  2008-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.